Pharmacological approaches to methamphetamine dependence: a focused review

L Karila, A Weinstein, HJ Aubin… - British journal of …, 2010 - Wiley Online Library
Methamphetamine dependence is a serious worldwide public health problem with major
medical, psychiatric, socioeconomic and legal consequences. Various neuronal …

Pharmacotherapy of amphetamine‐type stimulant dependence: an update

M Brensilver, KG Heinzerling… - Drug and alcohol …, 2013 - Wiley Online Library
Issues. Methamphetamine‐or amphetamine‐type stimulants are the second most frequently
used illicit drug worldwide, second only to cannabis. Behavioural treatments are efficacious …

Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial

N Jayaram-Lindström, A Hammarberg… - American Journal of …, 2008 - Am Psychiatric Assoc
Objective: Currently there is no approved pharmacotherapy for amphetamine dependence.
Recent human laboratory studies have demonstrated that naltrexone modulates some of the …

Pharmacotherapy for amphetamine dependence: A systematic review

NK Lee, L Jenner, A Harney, J Cameron - Drug and alcohol dependence, 2018 - Elsevier
Background Demand for treatment for amphetamine use is increasing internationally.
Establishing effective pharmacotherapy provides broader treatment options for people who …

Approaches to the development of medications for the treatment of methamphetamine dependence

FJ Vocci, NM Appel - Addiction, 2007 - Wiley Online Library
Background Methamphetamine abuse has become an increasing problem in both the
United States and globally with concomitant increases in adverse medical, social and …

New horizons for therapeutics in drug and alcohol abuse

B Jupp, AJ Lawrence - Pharmacology & therapeutics, 2010 - Elsevier
Alcohol, tobacco and illicit drug dependence represents a serious health and social issue
within the community. As drug dependence has become more widely recognized as a …

Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction

DN Cao, JJ Shi, W Hao, N Wu, J Li - European Journal of Pharmacology, 2016 - Elsevier
Addiction to amphetamine-type stimulants (ATS) is a serious worldwide public health
problem with major medical, psychiatric and socioeconomic consequences. However, no …

[图书][B] Pharmacology and treatment of substance abuse: Evidence and outcome based perspectives

LM Cohen, FL Collins Jr, A Young, DE McChargue… - 2013 - taylorfrancis.com
Given the prevalence of substance abuse in general clinical populations, it is important for
healthcare providers to have knowledge and skill in the treatment of these problems …

Immunopharmacotherapeutic advancements in addressing methamphetamine abuse

JC Lee, KD Janda - RSC Chemical Biology, 2021 - pubs.rsc.org
Methamphetamine (METH) is an illicit psychostimulant that is known to account for
substance abuse disorders globally, second only to opioids, yet has no approved …

Extended-release injectable naltrexone (XR-NTX) with intensive psychosocial therapy for amphetamine-dependent persons seeking treatment: a placebo-controlled …

V Runarsdottir, I Hansdottir, T Tyrfingsson… - Journal of addiction …, 2017 - journals.lww.com
Objective: Explore the efficacy of extended-release injectable naltrexone (XR-NTX) for
preventing relapse to amphetamine use. Method: Clinical trial of 100 amphetamine …